Editorial: On the cusp of rational CHO cell engineering.
With the emergence of additional data on genomic variants, a more detailed molecular understanding of cellular processes and enhanced capabilities in fine-tuned manipulation of cell behaviour, the coming years promise to be exciting game changers in the production of therapeutics in mammalian cells.